Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1982 2
1983 2
1984 3
1985 4
1989 2
1990 3
1991 4
1992 9
1993 9
1994 5
1995 11
1996 6
1997 5
1998 9
1999 4
2000 8
2001 5
2002 6
2003 8
2004 11
2005 6
2006 4
2007 4
2008 3
2009 3
2010 3
2012 1
2013 2
2014 2
2015 1
2016 4
2017 2
2018 1
2019 2
2020 4
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Novel dopamine receptors half a decade later.
Sokoloff P, Schwartz JC. Sokoloff P, et al. Trends Pharmacol Sci. 1995 Aug;16(8):270-5. doi: 10.1016/s0165-6147(00)89044-6. Trends Pharmacol Sci. 1995. PMID: 7482988 Review.
Functional models for the dopamine D3 receptor.
Griffon N, Sautel F, Pilon C, Lévesque D, Sokoloff P, Schwartz JC, Diaz J, Simon P, Costentin J, Mann A, Wermuth CG. Griffon N, et al. Among authors: sokoloff p. Biochem Soc Trans. 1996 Feb;24(1):193-8. doi: 10.1042/bst0240193. Biochem Soc Trans. 1996. PMID: 8674660 Review. No abstract available.
Dopamine D3 receptor: basic and clinical aspects.
Schwartz JC, Levesque D, Martres MP, Sokoloff P. Schwartz JC, et al. Among authors: sokoloff p. Clin Neuropharmacol. 1993 Aug;16(4):295-314. doi: 10.1097/00002826-199308000-00002. Clin Neuropharmacol. 1993. PMID: 8104095 Review.
The third dopamine receptor (D3): new perspectives in therapeutics.
Giros B, Sokoloff P, Martres MP, Lannfelt L, Andrieux M, Besançon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. Giros B, et al. Among authors: sokoloff p. Psychopharmacol Ser. 1993;10:82-93. doi: 10.1007/978-3-642-78010-3_8. Psychopharmacol Ser. 1993. PMID: 8103228 Review. No abstract available.
Localization and function of the D3 dopamine receptor.
Sokoloff P, Giros B, Martres MP, Andrieux M, Besancon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. Sokoloff P, et al. Arzneimittelforschung. 1992 Feb;42(2A):224-30. Arzneimittelforschung. 1992. PMID: 1586393 Review.
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, Håkansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, Bloch B, Bezard E. Guigoni C, et al. Among authors: sokoloff p. Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S25-9. doi: 10.1016/j.parkreldis.2004.11.005. Parkinsonism Relat Disord. 2005. PMID: 15885624 Review.
157 results